ITV Extension Study

NCT00332930 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens
BIOLOGICAL: HIV gag-pol antigens and interferon-gamma (IFN-y)

Sponsor

Kirby Institute

Collaborators

[object Object]
[object Object]